dr. brufsky on cobimetinib plus paclitaxel in tnbc
Published 7 years ago • 103 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:49
cobimetinib plus paclitaxel in tnbc
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
1:06
dr. brufsky on challenges in breast cancer
-
1:31
dr. brufsky discusses the tnacity trial
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
2:20
dr. brufsky on choosing when to do a multiparameter genomic assay
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
0:57
meet thoracic surgeon frank detterbeck, md, facs, fccp
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:55
an expert explains the three major treatment modalities in triple negative breast cancer
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
2:10
dr. brufsky on anastrozole versus tamoxifen in dcis